Patent · US Active

Compositions and methods for treating cancer

US8852590B2 · kind B2 · utility

3Cited by
12References
1Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 6, 2010
Grant dateOct 7, 2014
Priority date
Expiry dateJul 22, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating a cancer with an mTOR inhibitor and an anti-IGF-1 R antibody is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.